So, modification with basic amino acids may be a promising strategy to enhance the therapeutic index for anti-cancer agents such as Rh2 because of reduction of side effects on normal cells, enhancement of their anticancer activity as well as the increase of their stability. This evidence concerns the gene RHAG and cancer.